JPMorgan Downgrades QIAGEN to Neutral

JPMorgan has downgraded QIAGEN N.V. to a Neutral rating, setting a price target of $52. This follows Berenberg's decision to maintain a Hold rating while increasing its price target to $52.22. These changes indicate a continued assessment of QIAGEN's performance and strategic direction in the market.